Department of Ophthalmology, Osaka University Graduate School of Medicine, Suita, Japan.
Department of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, Ichikawa, Japan.
Cornea. 2023 Dec 1;42(12):1590-1600. doi: 10.1097/ICO.0000000000003343. Epub 2023 Aug 21.
There are no defined diagnostic criteria and severity classification for Fuchs endothelial corneal dystrophy (FECD), which are required for objective standardized assessments. Therefore, we performed a systematic literature review of the current diagnosis and severity classification of FECD.
We searched the Ovid MEDLINE and Web of Science databases for studies published until January 13, 2021. We excluded review articles, conference abstracts, editorials, case reports with <5 patients, and letters.
Among 468 articles identified, we excluded 173 and 165 articles in the first and second screenings, respectively. Among the 130 included articles, 61 (47%) and 99 (76%) mentioned the diagnostic criteria for FECD and described its severity classification, respectively. Regarding diagnosis, slitlamp microscope alone was the most frequently used device in 31 (51%) of 61 articles. Regarding diagnostic findings, corneal guttae alone was the most common parameter [adopted in 23 articles (38%)]. Regarding severity classification, slitlamp microscopes were used in 88 articles (89%). The original or modified Krachmer grading scale was used in 77 articles (78%), followed by Adami's classification in six (6%). Specular microscopes or Scheimpflug tomography were used in four articles (4%) and anterior segment optical coherence tomography in one (1%).
FECD is globally diagnosed by the corneal guttae using slitlamp examination, and its severity is predominantly determined by the original or modified Krachmer grading scale. Objective severity grading using Scheimpflug or anterior segment optical coherence tomography can be applied in the future innovative therapies such as cell injection therapy or novel small molecules.
目前缺乏针对 Fuchs 内皮角膜营养不良(FECD)的明确诊断标准和严重程度分级,这是进行客观标准化评估的必要条件。因此,我们对 FECD 的当前诊断和严重程度分级进行了系统的文献回顾。
我们在 Ovid MEDLINE 和 Web of Science 数据库中检索了截至 2021 年 1 月 13 日发表的研究。我们排除了综述文章、会议摘要、社论、少于 5 例患者的病例报告和信件。
在确定的 468 篇文章中,我们在第一轮和第二轮筛选中分别排除了 173 篇和 165 篇文章。在纳入的 130 篇文章中,有 61 篇(47%)和 99 篇(76%)分别提到了 FECD 的诊断标准和描述了其严重程度分级。在诊断方面,单独使用裂隙灯显微镜是 61 篇文章中最常用的设备(51%)。在诊断发现方面,单纯角膜后弹力层小滴是最常见的参数[在 23 篇文章(38%)中采用]。在严重程度分级方面,88 篇文章(89%)使用了裂隙灯显微镜。原始或改良的 Krachmer 分级量表在 77 篇文章(78%)中使用,其次是 Adami 分类在 6 篇(6%)中使用。共 4 篇文章(4%)使用共焦显微镜或 Scheimpflug 断层扫描,1 篇文章(1%)使用前节光学相干断层扫描。
全球范围内使用裂隙灯检查通过角膜后弹力层小滴来诊断 FECD,其严重程度主要由原始或改良的 Krachmer 分级量表确定。将来可以使用 Scheimpflug 或前节光学相干断层扫描等客观严重程度分级来应用于细胞注射治疗或新型小分子等创新疗法。